FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hack, V.
Right arrow Articles by Droge, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hack, V.
Right arrow Articles by Droge, W.

The FASEB Journal, Vol 11, 84-92, Copyright © 1997 by The Federation of American Societies for Experimental Biology

RESEARCH COMMUNICATIONS

Cystine levels, cystine flux, and protein catabolism in cancer cachexia, HIV/SIV infection, and senescence

V Hack, D Schmid, R Breitkreutz, C Stahl-Henning, P Drings, R Kinscherf, F Taut, E Holm and W Droge
Department of Immunochemistry, Deutsches Krebsforschungszentrum, Heidelberg, Germany.

Patients with skeletal muscle catabolism (cachexia) fail to conserve the skeletal muscle protein and release large amounts of nitrogen as urea. Previous studies suggest that the threshold for the conversion of amino acids into other forms of chemical energy and the concomitant production of urea are regulated by the plasma cystine level and hepatic cysteine catabolism. Studies of plasma amino acid exchange rates in the lower extremities now show that healthy young subjects regulate their plasma cystine level in a process that may be described as controlled constructive catabolism. The term controlled describes the fact that the release of cystine and other amino acids from the peripheral tissue is negatively correlated with (certain) plasma amino acid levels. The term constructive describes the fact that the release of cystine is correlated with an increase of the plasma cystine level. The regulation of the plasma cystine level is disturbed in conditions with progressive skeletal muscle catabolism including cancer, HIV infection, and old age. These conditions show also a low plasma glutamine:cystine ratio indicative of an impaired hepatic cystine catabolism. In HIV+ patients and SIV-infected macaques, a decrease of the plasma cystine level was found to coincide with the decrease of CD4+ T cells.


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
H. Sato, A. Shiiya, M. Kimata, K. Maebara, M. Tamba, Y. Sakakura, N. Makino, F. Sugiyama, K.-i. Yagami, T. Moriguchi, et al.
Redox Imbalance in Cystine/Glutamate Transporter-deficient Mice
J. Biol. Chem., November 11, 2005; 280(45): 37423 - 37429.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
W. Droge
Free Radicals in the Physiological Control of Cell Function
Physiol Rev, January 1, 2002; 82(1): 47 - 95.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
L. C. Lands, V. L. Grey, and A. A. Smountas
Effect of supplementation with a cysteine donor on muscular performance
J Appl Physiol, October 1, 1999; 87(4): 1381 - 1385.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
B Sido, V Hack, A Hochlehnert, H Lipps, C Herfarth, and W Droge
Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease
Gut, April 1, 1998; 42(4): 485 - 492.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by The Federation of American Societies for Experimental Biology.